Hamilton Lane (NASDAQ:HLNE) PT Raised to $182.00 at Morgan Stanley

Hamilton Lane (NASDAQ:HLNEGet Free Report) had its target price increased by equities researchers at Morgan Stanley from $140.00 to $182.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The firm presently has an “equal weight” rating on the stock. Morgan Stanley’s price objective would suggest a potential upside of 4.15% from the company’s previous close.

Other analysts have also issued research reports about the stock. Keefe, Bruyette & Woods boosted their price objective on shares of Hamilton Lane from $135.00 to $145.00 and gave the stock a “market perform” rating in a research report on Wednesday, August 7th. Wells Fargo & Company raised their price objective on Hamilton Lane from $156.00 to $170.00 and gave the company an “equal weight” rating in a report on Wednesday. JPMorgan Chase & Co. upped their target price on Hamilton Lane from $120.00 to $134.00 and gave the stock a “neutral” rating in a report on Wednesday, August 7th. UBS Group raised their price target on Hamilton Lane from $122.00 to $150.00 and gave the company a “neutral” rating in a research note on Wednesday, August 21st. Finally, The Goldman Sachs Group upped their price objective on Hamilton Lane from $139.00 to $147.00 and gave the stock a “neutral” rating in a research note on Thursday, October 3rd. Seven analysts have rated the stock with a hold rating, Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $154.67.

Check Out Our Latest Stock Report on Hamilton Lane

Hamilton Lane Stock Performance

Shares of NASDAQ:HLNE opened at $174.74 on Thursday. The firm’s 50 day simple moving average is $153.87 and its 200 day simple moving average is $132.97. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.72 and a quick ratio of 2.72. The company has a market capitalization of $9.47 billion, a price-to-earnings ratio of 40.17 and a beta of 1.19. Hamilton Lane has a fifty-two week low of $78.66 and a fifty-two week high of $177.62.

Hamilton Lane (NASDAQ:HLNEGet Free Report) last issued its quarterly earnings data on Tuesday, August 6th. The company reported $1.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.10 by $0.41. The business had revenue of $196.73 million during the quarter, compared to analyst estimates of $149.84 million. Hamilton Lane had a return on equity of 34.36% and a net margin of 26.99%. During the same period in the previous year, the firm earned $0.94 EPS. As a group, sell-side analysts forecast that Hamilton Lane will post 4.88 earnings per share for the current year.

Institutional Investors Weigh In On Hamilton Lane

A number of institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. boosted its position in shares of Hamilton Lane by 8.3% during the 1st quarter. Vanguard Group Inc. now owns 3,678,617 shares of the company’s stock valued at $414,801,000 after purchasing an additional 283,190 shares in the last quarter. Geneva Capital Management LLC acquired a new stake in Hamilton Lane in the first quarter valued at approximately $22,395,000. American Century Companies Inc. increased its holdings in shares of Hamilton Lane by 30.3% during the second quarter. American Century Companies Inc. now owns 580,768 shares of the company’s stock valued at $71,772,000 after acquiring an additional 135,040 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund bought a new stake in shares of Hamilton Lane during the first quarter valued at approximately $11,445,000. Finally, Capital World Investors acquired a new position in shares of Hamilton Lane during the first quarter worth approximately $9,724,000. Institutional investors own 97.40% of the company’s stock.

About Hamilton Lane

(Get Free Report)

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.

Read More

Analyst Recommendations for Hamilton Lane (NASDAQ:HLNE)

Receive News & Ratings for Hamilton Lane Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hamilton Lane and related companies with MarketBeat.com's FREE daily email newsletter.